PFS Stock Analysis: Provident Financial | NYSE
Banks - Regional | NYSE, USA | Market Cap: 2.970m USD | 12M Return: 24.6% | US74386T1051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 18.8M
EPS Trend: 72.9%
Qual. Beats: -1
Rev. Trend: 92.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Provident Financial Services, Inc. (NYSE: PFS) operates as the holding company for Provident Bank, a regional U.S. bank serving individuals, families, and businesses. Founded in 1839 and headquartered in Jersey City, New Jersey, the company offers a full suite of retail and commercial banking products, including checking, savings, money market, and certificate of deposit accounts, as well as IRAs.
The companys lending activities span commercial real estate (multi-family, retail, industrial, and office properties), commercial business loans, residential mortgages, construction loans, and consumer loans such as home equity products, personal loans, and auto financing. Beyond traditional banking, Provident provides cash management, remote deposit capture, online and mobile banking, business credit cards, and wealth management services including investment management, trust and estate administration, financial planning, and tax services.
As a regional bank holding company in the Financials sector, Provident generates revenue primarily through net interest income from its loan and deposit operations, supplemented by fee-based income from wealth management, insurance agency services, and real estate acquired through foreclosure. Its diversified mix of retail, commercial, and fee-based businesses is typical of mid-sized regional banks operating in concentrated geographic markets.
- Net interest margin compresses as Fed cuts rates
- Office CRE loan losses pressure credit costs
- Deposit costs rise amid regional bank competition
| Net Income: 310.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.27 > 1.0 |
| NWC/Revenue: -1.17k% < 20% (prev -1.19k%; Δ 14.87% < -1%) |
| CFO/TA 0.01 > 3% & CFO 328.6m > Net Income 310.2m |
| Net Debt (-1.01b) to EBITDA (451.0m): -2.23 < 3 |
| Current Ratio: 0.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (130.4m) vs 12m ago -0.05% < -2% |
| Gross Margin: 62.88% > 18% (prev 60.11%; Δ 2.77% > 0.5%) |
| Asset Turnover: 5.37% > 50% (prev 5.34%; Δ 0.03% > 0%) |
| Interest Coverage Ratio: 0.77 > 6 (EBIT TTM 389.1m / Interest Expense TTM 502.9m) |
| A: -0.62 (Total Current Assets 3.93b - Total Current Liabilities 19.9b) / Total Assets 25.8b |
| B: 0.05 (Retained Earnings 1.29b / Total Assets 25.8b) |
| C: 0.02 (EBIT TTM 389.1m / Avg Total Assets 25.3b) |
| D: 0.12 (Book Value of Equity 2.86b / Total Liabilities 23.0b) |
| Altman-Z'' = -3.64 = D |
| DSRI: 1.05 (Receivables 102.1m/94.6m, Revenue 1.36b/1.33b) |
| GMI: 0.96 (GM 60.11% / 62.88%) |
| AQI: 0.99 (AQ_t 0.84 / AQ_t-1 0.85) |
| SGI: 1.03 (Revenue 1.36b / 1.33b) |
| TATA: -0.00 (NI 310.2m - CFO 328.6m) / TA 25.8b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of November 20, 2026, the stock is trading at USD 21.67 with a total of 849,576 shares traded. Over the past week, the price has changed by -4.54%, over one month by -0.95%, over three months by -7.60% and over the past year by +24.60%.
Current recommended Stop Loss: 21.10 (which is 2.6% or 1.2 ATR below the current price).
Provident Financial has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PFS.
- StrongBuy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 27.8 | 28.4% |
P/E Trailing = 9.5672
P/E Forward = 9.0171
P/S = 3.2531
P/B = 1.0367
P/EG = 1.6065
Revenue TTM = 1.36b USD
EBIT TTM = 389.1m USD
EBITDA TTM = 451.0m USD
Long Term Debt = 2.73b USD (from longTermDebt, last quarter)
Short Term Debt = 95.0m USD (from shortTermDebt, last fiscal year)
Debt = 2.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.01b USD (calculated: Debt 2.82b - CCE 3.83b)
Enterprise Value = 1.96b USD (2.97b + Debt 2.82b - CCE 3.83b)
Interest Coverage Ratio = 0.77 (Ebit TTM 389.1m / Interest Expense TTM 502.9m)
EV/FCF = 6.54x (Enterprise Value 1.96b / FCF TTM 299.9m)
FCF Yield = 15.28% (FCF TTM 299.9m / Enterprise Value 1.96b)
FCF Margin = 22.05% (FCF TTM 299.9m / Revenue TTM 1.36b)
Net Margin = 22.80% (Net Income TTM 310.2m / Revenue TTM 1.36b)
Gross Margin = 62.88% ((Revenue TTM 1.36b - Cost of Revenue TTM 504.8m) / Revenue TTM)
Gross Margin QoQ = 59.41% (prev 62.06%)
Tobins Q-Ratio = 0.08 (Enterprise Value 1.96b / Total Assets 25.8b)
Interest Expense / Debt = 17.83% (Interest Expense 502.9m / Debt 2.82b)
Taxrate = 26.34% (110.9m / 421.1m)
NOPAT = 286.6m (EBIT 389.1m * (1 - 26.34%))
Current Ratio = 0.20 (Total Current Assets 3.93b / Total Current Liabilities 19.9b)
Debt / Equity = 0.98 (Debt 2.82b / totalStockholderEquity, last quarter 2.86b)
Debt / EBITDA = -2.23 (Net Debt -1.01b / EBITDA 451.0m)
Debt / FCF = -3.36 (Net Debt -1.01b / FCF TTM 299.9m)
Total Stockholder Equity = 2.87b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.22% (Net Income 310.2m / Total Assets 25.8b)
RoE = 10.82% (Net Income TTM 310.2m / Total Stockholder Equity 2.87b)
RoCE = 6.96% (EBIT 389.1m / Capital Employed (Equity 2.87b + L.T.Debt 2.73b))
RoIC = 4.76% (NOPAT 286.6m / Invested Capital 6.02b)
WACC = 10.55% (E(2.97b)/V(5.79b) * Re(8.10%) + D(2.82b)/V(5.79b) * Rd(17.83%) * (1-Tc(0.26)))
Discount Rate = 8.10% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 53.43 | Cagr: 11.08%
[DCF] Terminal Value 65.34% ; FCFF base≈421.7m ; Y1≈369.8m ; Y5≈298.8m
[DCF] Fair Price = 34.75 (EV 3.52b - Net Debt -1.01b = Equity 4.53b / Shares 130.4m; r=10.55% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 72.87 | EPS CAGR: 30.25% | SUE: -1.18 | # QB: -1
Revenue Correlation: 92.73 | Revenue CAGR: 31.57% | SUE: 0.58 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.62 | Chg30d=+0.27% | Revisions=-25% | Analysts=6
EPS current Year (2026-12-31): EPS=2.49 | Chg30d=+1.09% | Revisions=+62% | GrowthEPS=+10.7% | GrowthRev=+6.3%
EPS next Year (2027-12-31): EPS=2.58 | Chg30d=-0.64% | Revisions=+0% | GrowthEPS=+3.6% | GrowthRev=+5.8%
[Analyst] Revisions Ratio: +36% (up=6, down=2)